英文名称 | zelasudil |
---|---|
别名 | example 290 [EP3743420B1] |
英文别名 | example 290 [EP3743420B1] |
IUPAC Name | 4-[5-[(4-cyclopropyl-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-N-(2,2-difluoroethyl)benzamide |
---|---|
INCHI | InChI=1S/C22H21F2N7O/c1-31-22(27-17-9-8-16-15(10-26-29-16)19(17)12-2-3-12)28-20(30-31)13-4-6-14(7-5-13)21(32)25-11-18(23)24/h4-10,12,18H,2-3,11H2,1H3,(H,25,32)(H,26,29)(H,27,28,30) |
InChi Key | HSZPZEGJQCFGDE-UHFFFAOYSA-N |
Canonical SMILES | Cn1c(nc(n1)c1ccc(cc1)C(=O)NCC(F)F)Nc1c(c2c(cc1)[nH]nc2)C1CC1 |
PubChem CID | 155792249 |
PubChem CID | 155792249 |
---|---|
CAS Registry No. | 2365193-22-0 |
Ligand ID | 12386 |
---|---|
名称 | zelasudil |
别名 | example 290 [EP3743420B1] |
类别 | Synthetic organic |
学名 | 4-[5-[(4-cyclopropyl-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-N-(2,2-difluoroethyl)benzamide |
生物活性评价 |
The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in |
评价 |
This is the chemical structure for the INN zelasudil (a Rho-associated [ROCK] kinase inhibitor). The structure is claimed in Redx Pharma's patent EP3743420B1 |